跳至主要内容
临床试验/NCT01337063
NCT01337063已完成不适用

Multi-Center Medication Reconciliation Quality Improvement Study

Brigham and Women's Hospital12 个研究点 分布在 1 个国家目标入组 1,836 人开始时间: 2011年3月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
1,836
试验地点
12
主要终点
The primary outcome will be unintentional medication discrepancies in admission orders and discharge orders with potential for patient harm

研究概览

简要总结

Patients often have problems after they leave the hospital, in part because errors are made in the medications they are prescribed. The goal of this project is to develop a more accurate and safe medication prescription process when patients enter and leave the hospital and implement this process at six U.S. hospitals. The investigators will measure the success of the project and develop lessons learned so this process can be applied to other hospitals.

详细描述

Unintentional medication discrepancies during transitions in care (such as hospitalization and subsequent discharge) are very common and represent a major threat to patient safety. One solution to this problem is medication reconciliation. In response to Joint Commission requirements, most hospitals have developed medication reconciliation processes, but some have been more successful than others, and there are reports of pro-forma compliance without substantial improvements in patient safety. There is now collective experience about effective approaches to medication reconciliation, but these have yet to be consolidated, evaluated rigorously, and disseminated effectively.

This project's findings should provide valuable lessons to all hospitals regarding the best ways to design and implement medication reconciliation interventions to improve medication safety during transitions in care.

SPECIFIC AIMS:

Aim 1: Develop a toolkit consolidating the best practice recommendations for medication reconciliation

Aim 2: Conduct a multi-center mentored quality improvement project in which each site adapts the tools for its own environment and implements them

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 and over
  • Admitted to inpatient medical or surgical services

排除标准

  • Vulnerable populations (pregnant women, prisoners, institutionalized individuals)
  • Under 18 years
  • Hospital staff subjects:
  • Personnel directly involved in the medication reconciliation process, which depending on the site might include residents, physician assistants, inpatient attending physicians, nurses, pharmacists, and pharmacy technicians.

研究组 & 干预措施

Pre-intervention

No Intervention

Usual care regarding medication reconciliation as currently practiced at each participating site.

Intervention

Experimental

Improved medication reconciliation process using continuous quality improvement methods, mentored implementation, and an implementation guide.

干预措施: Mentored medication reconciliation quality improvement (Other)

结局指标

主要结局

The primary outcome will be unintentional medication discrepancies in admission orders and discharge orders with potential for patient harm

时间窗: 6 months prior to implementation of intervention to 21 months during intervention

The primary outcome will be determined by a study pharmacist who will take a "gold standard" medication history on 5 patients per week, then compare that history to the medical team's medication history, to admission orders, and to discharge orders. Any unintentional medication discrepancies in orders will be recorded. A physician adjudicator will then make a final determination regarding whether an error occurred, the type of error, the potential for patient harm, and the potential severity.

次要结局

  • Patient satisfaction(6 months prior to implementation of intervention to 21 months during intervention)
  • Total medication discrepancies(6 months prior to implementation of intervention to 21 months during intervention)
  • Administrative outcomes(6 months prior to implementation of intervention to 21 months during intervention)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jeffrey L. Schnipper, MD.,MPH.

Associate Professor of Medicine

Brigham and Women's Hospital

研究点 (12)

Loading locations...

相似试验